A line of mouse 3T3 cells lacking deoxythymidine kinase (dTK-) was stably transformed to the dTK' phenotype after exposure to ultraviolet-irradiated equine herpesvirus type 1 (EHV-1). Deoxythymidine kinase (dTK) was purified from the biochemically transformed mouse cells by affinity chromatography on deoxythymidine-Sepharose. The purified dTK from EHV-1-transformed 3T3 cells was identical to the dTK purified from dTK-3T3 cells lyrically infected with EHV-1 with respect to its electrophoretic mobility, molecular weight, substrate specificity, phosphate donor specificity, and immunological specificity. The sedimentation velocity of the purified dTK from the transformed 3T3 cells was similar to that previously reported for the enzyme in lytically infected dTK-3T3 cells, and its molecular weight was estimated to be 87,000. Antiserum prepared against the EHV-1 dTK induced in horse cells inactivated the dTK purified from the transformed mouse cells. The Km for deoxythymidine (5 tM) of purified dTK from the EHV-1-transformed cells was the same as that reported for the EHV-1-induced dTK. These results further support the notion that the dTK acquired by dTK-mouse 3T3 cells after transformation by EHV-1 is of viral and not of cellular origin.
contain herpes simplex virus-specific deoxyribonucleic and ribonucleic acids (8, 13, 16, 28) .
These data indicate-that the dTK acquired by the transformed cell is specified by the herpesvirus genome.
We have recently used the affinity column chromatography procedures developed by Kowal and Markus (15) to partially purify and identify the new dTK induced in dTK-3T3 cells lyrically infected with EHV-1 (3). Using a modification of this chromatographic procedure of Kowal and Markus (15) as described by Lee and Cheng (17) , we have now purified the dTK present in EHV-1 biochemically transformed mouse dTK-3T3 cells. In this communication we report the physical, biochemical, and immunological properties of this purified transformed cell kinase and show it to be identical to the dTK purified from dTK-3T3 cells lyrically infected with EHV-1. Green, Massachusetts Institute of Technology, Cambridge, Mass., and were grown in Eagle minimal essential medium supplemented with 5% fetal bovine serum (Flow Laboratories, Rockville, Md.). The dTK-3T3 cells transformed by EHV-1 were isolated in Eagle minimal essential medium containing lo-4 M hypoxanthine, 6 x 10-7 M aminopterin, and 2 x 105 M thymidine (HAT medium) and were then grown in HAT medium (to maintain selective pressure) for more than 60 passages. Further characterization of these biochemical transformants has been previously reported (1) .
Extraction and assay of dTK. Cytosol fractions of cells were prepared by the method of Cheng and Ostrander (6) and were assayed for dTK activity as described by Lee and Cheng (17) . Electrophoretic migration of dTK in polyacrylamide gels was determined by the procedure of Lee and Cheng (17) .
Antibody inhibition assays. Antiserum to EHV-1 dTK induced in -lytically infected KyED cells was prepared as previously reported (1-3). Inhibition of dTK by antibody was performed by incubation of the enzyme for 12 h at 20C with dilutions of the immune serum, using preimmune serum as the diluent. A 40-ld portion of each enzyme antisera mixture was then assayed for dTK activity as described above.
Glycerol gradient centrifugation. The molecular weight of the dTK purified from EHV-1-transformed dTK-3T3 cells was estimated by centrifugation in glycerol gradients using the method of Martin and Ames (20) . A 0.1-ml sample of purified enzyme was layered onto a 4.75-ml, 15 to 30% (vol/vol) glycerol gradient prepared in a buffer containing 50 mM tris(hydroxymethyl)aminomethane-hydrochloride (pH 7.5), 2.4 mM dithiothreitol, and 50 ,iM deoxythymidine (dT). Samples of lactate dehydrogenase and hemoglobin were added to the same gradient as molecular weight markers. The gradients were centrifuged for 36 h at 40,000 rpm at 4°C in an SW50.1 rotor (Beckman Instruments, Palo Alto, Calif.). Fractions (0.1 ml) were collected and assayed for dTK activity as described. Lactate dehydrogenase activity was assayed by the method of Reeves and Fimognari (27) , and hemoglobin was located by its absorption at 555 nm.
Preparation of affinity gel for dTK. The procedures were essentially the same as those described by Kowal and Marcus (15) with the alterations of Lee and Cheng (17) . Briefly, 120 mg of p-nitrophenylthymidine 3'-monophosphate was passed through a Dowex 50 column (H+ 200-400 mesh, 3 by 8 cm) with water as the eluting solvent. The activated compound was reduced to p-aminophenylthymidine 3'-monophosphate under 1.5 atm of H2 in the presence of palladium on carbon. The unreacted compound was eluted from the reduced compound by passage through a Dowex 50 column (H+, 200-400 mesh, 3 by 13 cm). The reduced compound was lyophilized and linked to activated CH-Sepharose 4B, and unreacting ester groups were blocked as described by the manufacturer (25 (3, 5, 7) . A typical elution profile for the EHV-1-transformed cell dTK is presented in Fig. 1 . The concentrations of dT, tris(hydroxymethyl)-aminomethane-hydrochloride, and KC1 required to elute the transformed cell dTK from the affinity column (0.45 M, 300 ,uM, and 0.8 M, respectively) were different from those required for column elution of the cytosol dTK from dTK+ 3T3 cells but the same as those required (-) . Cell extracts were loaded onto the affinity columns, which were then eluted in a stepwise fashion with buffers containing the indicated concentrations of tris-(hydroxymethyl)aminomethane-hydrochloride, dT, and KCI. Fractions of 1.5 ml were collected and assayed for dTK activity. Arrows mark the elution positions of dTKi 3T3 cytosol dTK (A), 3T3 mitochondrial dTK (B), and EHV-1 dTK (C) (3).
for the dTK from dTK-3T3 cells lyrically infected with EHV-1 (3). The partially purified dTK from activity peak C (see Fig. 1 ) was used in all subsequent studies in characterization of the enzyme. Enzyme present in this peak of activity represented a 79-fold purification with an overall recovery of 11% of the enzyme activity (Table 1) .
Polyacrylamide gel electrophoresis. Figure 2 shows that when crude and purified dTK's were electrophoresed as described in Materials and Methods, the electrophoretic mobility (Rf) of the crude EHV-1 enzyme was 0.25, whereas that of the purified enzyme was 0.21. This is in agreement with the values found for the EHV-1 dTK in crude extracts of EHV-1-infected dTK-3T3 cells (3) and that previously reported for the dTK from crude extracts of EHV-1-transformed 3T3 cells (1) .
Glycerol gradient centrifugation. The sedimentation velocity of the purified dTK from the transformed 3T3 cells was determined by centrifugation in 15 to 30% (vol/vol) glycerol gradients with the internal marker proteins hemoglobin and lactate dehydrogenase (Fig. 3) . The sedimentation rate of the EHV-1-transformed 3T3 cell dTK (5.2S) was similar to that previously reported for the lytic enzyme (3) and results in a computed molecular weight of 87,000. This value is in agreement with value of 85,000 reported by Allen et al. Nucleoside triphosphates as phosphate donors for dTK activity. Table 2 shows that adenosine 5'-triphosphate and cytidine 5'-triphosphate acted as the best phosphate donors for the affinity chromatography-purified dTK from the EHV-1-transformed 3T3 cells. It can be seen that these data are in agreement with those obtained using purified dTK from dTK-3T3 cells lytically infected with EHV-1 (3). The other nucleoside triphosphates could also serve as phosphate donors for the transformed cell dTK but to a lesser degree. Deoxythymidine a The assays were performed under the conditions described in the text, except that adenosine 5'-triphos- agrees with the value previously reported for the purified viral enzyme (3). Deoxycytidine was not a substrate for the transformed dTK (data not shown).
Antiserum inhibition of purified EHV-1-transformed dTK. Antiserum to EHV-1-induced dTK prepared in rabbits as previously described (1) was tested for its ability to inhibit the dTK activity of the dTK purified from EHV-1-transformed cells. The activities of the various purified dTK's were made equal by dilution, and antiserum inhibition was carried out by incubating the enzyme extract with an equal volume of immune serum. Figure 5 demonstrates that 10 /J of antiserum inhibited the purified viral dTK from dTK-3T3 cells lytically infected with EHV-1 (3) and from dTK-3T3 cells biochemically transformed by ultraviolet-inactivated EHV-1 by at least 90%. In contrast, the anti-EHV-1 serum did not inhibit the purified host cytosol or mitochondrial dTK (3; Fig. 5 ). Incubation of the purified enzymes with dilutions of preimmune serum resulted in no loss of any of the purified dTK activity (data not shown). DISCUSSION We have used the dT-Sepharose affinity chromatography technique to purify the dTK from EHV-1-transformed dTK-3T3 cells. The elution profile of the enzyme from the affinity column was similar to that of the dTK induced by lytic infection of dTK-3T3 cells by EHV-1 (3). The salt concentration required to elute the dTK was higher than that reported for elution of other herpesviruses dTK's (5, 6) .
Electrophoresis of the affinity column-puri- (5, 6, 12, 14) .
We have shown by the results reported in this paper that the new dTK acquired by dTK-3T3 cells upon transformation by ultraviolet lightinactivated EHV-1 is identical to the dTK expressed in cells lytically infected with the virus with respect to its electrophoretic mobility, phosphate donors, molecular weight, Km for dT, and immunological specificity. These results provide further evidence that the dTK acquired by dTK-3T3 cells after transformation with EHV-1 is coded by the viral genome.
